loading
前日終値:
$18.13
開ける:
$18.15
24時間の取引高:
27,795
Relative Volume:
0.03
時価総額:
$1.05B
収益:
-
当期純損益:
$-100.44M
株価収益率:
-8.2748
EPS:
-2.22
ネットキャッシュフロー:
$-105.32M
1週間 パフォーマンス:
-4.45%
1か月 パフォーマンス:
-15.44%
6か月 パフォーマンス:
-34.23%
1年 パフォーマンス:
-49.78%
1日の値動き範囲:
Value
$18.05
$18.46
1週間の範囲:
Value
$18.05
$20.25
52週間の値動き範囲:
Value
$13.22
$45.37

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Name
名前
Structure Therapeutics Inc Adr
Name
セクター
Healthcare (1161)
Name
電話
(628) 229-9277
Name
住所
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Name
職員
183
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
GPCR's Discussions on Twitter

GPCR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GPCR
Structure Therapeutics Inc Adr
18.38 1.13B 0 -100.44M -105.32M -2.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.10 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
551.40 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.26 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.88 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.39 27.29B 3.81B -644.79M -669.77M -6.24

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-02 開始されました Citigroup Buy
2025-02-28 開始されました William Blair Outperform
2025-01-08 開始されました Stifel Buy
2024-12-04 開始されました H.C. Wainwright Buy
2024-09-23 開始されました Morgan Stanley Overweight
2024-05-21 開始されました JP Morgan Overweight
2024-04-09 開始されました Cantor Fitzgerald Overweight
2023-10-19 開始されました JMP Securities Mkt Outperform
2023-07-27 開始されました Piper Sandler Overweight
2023-05-25 再開されました Jefferies Buy
2023-02-28 開始されました BMO Capital Markets Outperform
2023-02-28 開始されました Guggenheim Buy
2023-02-28 開始されました Jefferies Buy
2023-02-28 開始されました SVB Securities Outperform
すべてを表示

Structure Therapeutics Inc Adr (GPCR) 最新ニュース

pulisher
Jul 17, 2025

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire

Jul 17, 2025
pulisher
Jul 16, 2025

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Eli Lilly & Co (LLY) - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS) - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

H.C. Wainwright Sticks to Its Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Has $14.24 Million Stock Holdings in Universal Display Corporation (NASDAQ:OLED) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Decreases Stock Holdings in Shift4 Payments, Inc. (NYSE:FOUR) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Sells 11,305 Shares of Nova Ltd. (NASDAQ:NVMI) - Defense World

Jul 13, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP), Amedisys (AMED) and Xoma (XOMA) - The Globe and Mail

Jul 06, 2025
pulisher
Jul 03, 2025

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Average Rating of “Buy” from Brokerages - Defense World

Jul 03, 2025
pulisher
Jul 02, 2025

Scage Future shares rise 2.16% in after-hours after extending business merger agreement deadline and establishing ADR facility. - AInvest

Jul 02, 2025
pulisher
Jun 25, 2025

Structure Therapeutics Holds 2025 Annual Shareholders Meeting - TipRanks

Jun 25, 2025
pulisher
Jun 24, 2025

Structure Therapeutics (NASDAQ:GPCR) Receives “Market Outperform” Rating from JMP Securities - Defense World

Jun 24, 2025
pulisher
Jun 23, 2025

Analyst Coverage Updates: June 23rd, 2025 - The Globe and Mail

Jun 23, 2025
pulisher
Jun 20, 2025

Breakthrough Oral Obesity Drug Matches Injectable Results, Shows Added Benefits With Wegovy in Trial Data - Stock Titan

Jun 20, 2025
pulisher
Jun 18, 2025

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail

Jun 18, 2025
pulisher
Jun 14, 2025

Data-Based Insights About Structure Therapeutics Inc ADR (GPCR) - Stocksregister

Jun 14, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Comments on GPCR FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarketsNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates GPCR FY2025 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Oral Proteins and Peptides Market Report Latest Trends and Future Opportunities Analysis - openPR.com

Jun 09, 2025
pulisher
Jun 08, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Structure Therapeutics, Inc.: Catalyst-Rich Outlook and Strategic Preparations Support Buy Rating - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Has $1.47 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Viking Therapeutics at Jefferies Conference: Promising Weight Loss Drug - Investing.com

Jun 05, 2025
pulisher
Jun 03, 2025

GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health - The National Law Review

Jun 03, 2025
pulisher
May 29, 2025

Structure Therapeutics Set for Jefferies and Goldman Sachs Healthcare Conference Presentations in June - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints - standard-journal.com

May 29, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Increases Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

May 28, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Makes New $304,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

May 28, 2025
pulisher
May 28, 2025

Bucking Biotech's Downward Trend, Circle Pharma Heads To Larger Space - Bisnow

May 28, 2025
pulisher
May 26, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Novo Nordisk (NVO), Beam Therapeutics (BEAM) and TScan Therapeutics (TCRX) - The Globe and Mail

May 26, 2025
pulisher
May 22, 2025

Structure Therapeutics’ SWOT analysis: oral obesity drug stock poised for growth - Investing.com

May 22, 2025
pulisher
May 20, 2025

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Arcellx Inc (ACLX) and Belite Bio, Inc. ADR (BLTE) - The Globe and Mail

May 20, 2025
pulisher
May 17, 2025

Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $78.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Relmada Therapeutics (RLMD) and Roivant Sciences (ROIV) - The Globe and Mail

May 16, 2025
pulisher
May 13, 2025

Structure Therapeutics (NASDAQ:GPCR) Price Target Lowered to $75.00 at HC Wainwright - Defense World

May 13, 2025
pulisher
May 12, 2025

FY2025 Earnings Forecast for GPCR Issued By Leerink Partnrs - Defense World

May 12, 2025
pulisher
May 09, 2025

Envestnet Asset Management Inc. Has $201,000 Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

May 09, 2025
pulisher
May 09, 2025

Tower Research Capital LLC TRC Acquires 3,549 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - The AM Reporter

May 09, 2025
pulisher
May 09, 2025

Structure Therapeutics Reports Increased Losses Amid Rising R&D Costs - TipRanks

May 09, 2025
pulisher
May 08, 2025

Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights - Stock Titan

May 08, 2025
pulisher
May 07, 2025

Wells Fargo & Company MN Boosts Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

May 07, 2025
pulisher
May 07, 2025

Analyzing Ratios: Structure Therapeutics Inc ADR (GPCR)’s Financial Story Unveiled - DWinneX

May 07, 2025
pulisher
May 07, 2025

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), AnaptysBio (ANAB) and Alignment Healthcare (ALHC) - The Globe and Mail

May 07, 2025
pulisher
May 06, 2025

Structure Therapeutics Inc ADR (NASDAQ: GPCR) Is Up 1.57% So Far This Year: What Will Happen Next? - Stocksregister

May 06, 2025
pulisher
May 05, 2025

Structure Therapeutics (NASDAQ:GPCR) Research Coverage Started at Citigroup - Defense World

May 05, 2025
pulisher
May 02, 2025

Structure Therapeutics Inc ADR (GPCR) expanding its growth trajectory ahead - Sete News

May 02, 2025
pulisher
May 02, 2025

Buy Recommendation for Structure Therapeutics: Promising Pipeline and Obesity Treatment Market Potential - TipRanks

May 02, 2025
pulisher
May 02, 2025

Citi sets Structure Therapeutics stock Buy rating, $60 target By Investing.com - Investing.com India

May 02, 2025
pulisher
May 01, 2025

Technical analysis of Stoke Therapeutics Inc (STOK) stock chart patterns - uspostnews.com

May 01, 2025

Structure Therapeutics Inc Adr (GPCR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.75
price up icon 0.32%
$35.67
price up icon 0.22%
$102.59
price up icon 0.20%
$26.90
price up icon 1.35%
$109.96
price up icon 0.27%
biotechnology ONC
$293.24
price up icon 0.33%
大文字化:     |  ボリューム (24 時間):